Anne P. Spencer

1.0k total citations · 1 hit paper
22 papers, 704 citations indexed

About

Anne P. Spencer is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Anne P. Spencer has authored 22 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 4 papers in Pharmacology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Anne P. Spencer's work include Heart Failure Treatment and Management (6 papers), Pharmaceutical Practices and Patient Outcomes (3 papers) and Pharmaceutical studies and practices (2 papers). Anne P. Spencer is often cited by papers focused on Heart Failure Treatment and Management (6 papers), Pharmaceutical Practices and Patient Outcomes (3 papers) and Pharmaceutical studies and practices (2 papers). Anne P. Spencer collaborates with scholars based in United States, Czechia and Türkiye. Anne P. Spencer's co-authors include Robin J. Trupp, Davy Cheng, Cindy L. O’Bryant, Robert L. Page, C. Michael Stein, Bonnie Ky, JoAnn Lindenfeld, Courtney L. Bickford, Deborah Stier Carson and William E. Smith and has published in prestigious journals such as Circulation, Anaesthesia and PharmacoEconomics.

In The Last Decade

Anne P. Spencer

20 papers receiving 666 citations

Hit Papers

Drugs That May Cause or Exacerbate Heart Failure 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne P. Spencer United States 10 292 154 90 78 77 22 704
Marisa Battistella Canada 16 271 0.9× 180 1.2× 95 1.1× 77 1.0× 66 0.9× 73 906
Gianfranco Fonte Italy 12 212 0.7× 101 0.7× 131 1.5× 40 0.5× 63 0.8× 36 549
David Battleman United States 17 607 2.1× 65 0.4× 71 0.8× 60 0.8× 209 2.7× 32 1.1k
James S. Kalus United States 21 678 2.3× 162 1.1× 88 1.0× 143 1.8× 178 2.3× 71 1.3k
Tien M. H. Ng United States 16 425 1.5× 60 0.4× 136 1.5× 53 0.7× 96 1.2× 52 830
David A. Kuhl United States 18 147 0.5× 57 0.4× 147 1.6× 30 0.4× 131 1.7× 41 824
K.W. Woodhouse United Kingdom 13 122 0.4× 294 1.9× 53 0.6× 73 0.9× 193 2.5× 23 1.3k
Sipke T. Visser Netherlands 15 155 0.5× 54 0.4× 51 0.6× 63 0.8× 112 1.5× 28 641
Jamie L Fleet Canada 16 228 0.8× 79 0.5× 250 2.8× 45 0.6× 187 2.4× 48 992
Ea Wha Kang South Korea 19 184 0.6× 107 0.7× 142 1.6× 79 1.0× 116 1.5× 59 1.2k

Countries citing papers authored by Anne P. Spencer

Since Specialization
Citations

This map shows the geographic impact of Anne P. Spencer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne P. Spencer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne P. Spencer more than expected).

Fields of papers citing papers by Anne P. Spencer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne P. Spencer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne P. Spencer. The network helps show where Anne P. Spencer may publish in the future.

Co-authorship network of co-authors of Anne P. Spencer

This figure shows the co-authorship network connecting the top 25 collaborators of Anne P. Spencer. A scholar is included among the top collaborators of Anne P. Spencer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne P. Spencer. Anne P. Spencer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Page, Robert L., Cindy L. O’Bryant, Davy Cheng, et al.. (2016). Drugs That May Cause or Exacerbate Heart Failure. Circulation. 134(6). e32–69. 324 indexed citations breakdown →
2.
Denus, Simon de, et al.. (2008). Key Articles and Guidelines in the Management of Hypertension: 2008 Update. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(8). 1041–1058. 9 indexed citations
3.
Burke, John M., William A. Miller, Anne P. Spencer, et al.. (2008). Clinical Pharmacist Competencies. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(6). 806–815. 126 indexed citations
4.
Spencer, Anne P., et al.. (2007). Prevalence of Anemia in Clinic Patients with Heart Failure and Cost Analysis of Epoetin Treatment. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(5). 707–714. 5 indexed citations
5.
Spencer, Anne P., et al.. (2006). Practice activity patterns of dentists in Australia. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 3 indexed citations
6.
Bickford, Courtney L. & Anne P. Spencer. (2006). Adherence to the NASPE Guideline for Amiodarone Monitoring at a Medical University. Journal of Managed Care Pharmacy. 12(3). 254–259. 23 indexed citations
7.
Lunsford, Shayna L., et al.. (2005). Experience with an Adult Alcohol Withdrawal Syndrome Practice Guideline in Internal Medicine Patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(8). 1073–1083. 20 indexed citations
8.
Spencer, Anne P., et al.. (2005). Cardiovascular Drug Therapy in Women. The Journal of Cardiovascular Nursing. 20(6). 410–419.
9.
Bickford, Courtney L. & Anne P. Spencer. (2005). Biliary Sludge and Hyperbilirubinemia Associated with Ceftriaxone in an Adult: Case Report and Review of the Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(10). 1389–1395. 34 indexed citations
10.
Spencer, Anne P., et al.. (2004). Parecoxib for Parenteral Analgesia in Postsurgical Patients. Annals of Pharmacotherapy. 38(5). 882–886. 14 indexed citations
11.
Spencer, Anne P., et al.. (2004). Assessment of Hypothyroidism in Patients with Chronic Heart Failure. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(3). 358–361.
12.
Spencer, Anne P., et al.. (2004). Keeping Your Patient With Heart Failure Safe. Archives of Internal Medicine. 164(7). 709–709. 37 indexed citations
13.
Coleman, Craig I, James S. Kalus, C Michael White, et al.. (2004). Cost Effectiveness of Ibutilide With Prophylactic Magnesium in the Treatment of Atrial Fibrillation. PharmacoEconomics. 22(13). 877–883. 7 indexed citations
14.
Spencer, Anne P.. (2003). Digoxin in heart failure. Critical Care Nursing Clinics of North America. 15(4). 447–452. 2 indexed citations
15.
Spencer, Anne P., et al.. (2002). Stability of Furosemide in Human Albumin Solution. Annals of Pharmacotherapy. 36(3). 423–426. 2 indexed citations
16.
Spencer, Anne P.. (2000). Vitamin E: cautionary issues. Current Treatment Options in Cardiovascular Medicine. 2(2). 1–3. 1 indexed citations
17.
Spencer, Anne P.. (2000). Hormone Replacement Therapy Should Be Administered as Secondary Prevention of Coronary Artery Disease. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(9). 1028–1033. 1 indexed citations
18.
Spencer, Anne P., Deborah Stier Carson, & Michael A. Crouch. (1999). Vitamin E and Coronary Artery Disease. Archives of Internal Medicine. 159(12). 1313–1313. 43 indexed citations
19.
Cruickshank, R., Anne P. Spencer, & F.R. ELLIS. (1996). Pretreatment with controlled‐release morphine for pain after hysterectomy. Anaesthesia. 51(12). 1097–1101. 6 indexed citations
20.
Schwartz, Arthur, et al.. (1972). The effects of levodopa therapy in patients with Parkinson's disease. I. Clinical response.. PubMed. 107(10). 973–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026